| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |